mask-1954673_1280

Chinese coronavirus set to be put on international health emergency list

January 22, 2020
Research and Development Ebola, Public Health Emergency, WHO, World Health Organisation, Wuhan, polio, swine flu

The World Health Organisation (WHO) is expected to trigger a Public Health Emergency over the Wuhan coronavirus outbreak, meaning it …

No NICE recommendation for AstraZeneca’s Tagrisso in EGFR+ lung cancer

January 22, 2020
Research and Development, Sales and Marketing AstraZeneca, NICE, Tagrisso, pharma

AstraZenecaโ€™s Tagrisso (osimertinib) has been knocked back for routine use on the NHS in England and Wales by the drug …

Novartis establishes its new legal entity in Vietnam

January 22, 2020
Research and Development Novartis, Novartis Vietnam, oncology, pharma

Novartis has inaugurated its new legal entity in Vietnam, Novartis Vietnam Co Ltd, and has become one of the first …

roche__tree

EU approval for Roche’s Polivy combo in relapsed/refractory B-cell lymphoma

January 21, 2020
Manufacturing and Production, Sales and Marketing Cancer, Polivy, Roche, lymphoma, pharma

The European Commission has awarded conditional marketing approval to Rocheโ€™s Polivy (polatuzumab vedotin), it has been revealed.

Janssenโ€™s ulcerative colitis medicine not recommended by NICE for use in adults

January 21, 2020
Manufacturing and Production IBS, Irrated Bowels, NHS, NICE, bowel, ulcerative colitis

NICE has published draft guidance which does not recommend Stelara (ustekinumab) for treating moderately to severely active ulcerative colitis in …

jazz_pharma

Jazz Pharma’s Sunosi becomes first EU-approved drug of its kind in narcolepsy and sleep apnoea

January 21, 2020
Manufacturing and Production, Sales and Marketing jazz pharmaceuticals, narcolepsy, pharma

Jazz Pharmaceuticals has secured approval from the European Commission for Sunosi (solriamfetol), it has emerged, as a therapy to improve …

29419203133_3c3c14e63e_z

Cardiff University team discovers new method of killing cancers

January 21, 2020
Manufacturing and Production Cancer, Cancer cures, Cancerous, Cardiff University, T cell, cells, immune system, immunity, t-cell

A team at Cardiff University have discovered a new part of the human immune system that could be harnessed to …

Novartis’ Mayzent granted license by the European Medicines Agency

January 21, 2020
Manufacturing and Production CNS, European Medicines Agency, NHS, NICE, Novartis

The European Medicines Agency (EMA) has granted a licence for the use of Mayzent (siponimod) in the treatment of certain …

dw-anzcxqaqavhl

FDA warning letters to Indian pharmaceutical companies double in 2019

January 20, 2020
Sales and Marketing Indian Pharma, Indian Pharmaceuticals

Indian pharmaceutical firms received more than double the amount of warning letters in the first ten months of 2019 compared …

fda2outsideweb

Lynparza secures accelerated FDA review for metastatic castration-resistant prostate cancer

January 20, 2020
Sales and Marketing Cancer, FDA, lynparza, pharma

Following the recommendation of the tablet formulation of the drug for use on the NHS in England and Wales, news …

gettyimages-952692342-5c16809146e0fb0001dee456

Collaborating to realise the potential of precision medicine

January 20, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Precision Medicine, feature, pharma

Healthcare is an evolving continuum, and while traditional strategies have seen improvements to patient outcomes over time, voices in the …

26419186961_6507de1a5d_b

US judge slashes Johnson & Johnson damages in Risperdal case

January 20, 2020
Sales and Marketing Big Pharma, Johnson & Johnson, Johnson & Johnson talc powder

A judge in Philadelphia has reduced the amount of damages Johnson & Johnson was ordered to pay by a jury …

NICE turns down Bayer’s tumour-agnostic therapy Vitrakvi over evidence concerns

January 20, 2020
Sales and Marketing Bayer, Cancer, NICE, Vitravki

UK drug watchdog NICE has turned down Bayerโ€™s Vitrakvi (larotrectinib) as a tumour-agnostic treatment solution on the NHS after it …

mask-1954673_1280

WHO officials say Wuhan viral pneumonia outbreak can be passed from person to person

January 20, 2020
Sales and Marketing China, Sars, Viral pneumonia, WHO, World Health Organisation, Wuhan Outbreak

The viral pneumonia outbreak that began in Wuhan China can spread between person to person, according to health experts at …

steven_hildemann

Ipsen appoints new Exec VP and Chief Medical Officer

January 17, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen, pharma

Ipsen has named Dr Steven Hildemann as its new Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs …

4420456374_64a3d7e6aa_88_2

Top Ten most popular articles on Pharmafile.com this week

January 17, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, European Commission, FDA, Pakistan, Sanofi, Teva

Pakistan is cracking down on corruption and has registered cases against 200 pharmaceutical companies, while in the US the FDA …

landing-hero-images1

Japan welcomes approval of ViiV’s Dovato for HIV-1

January 17, 2020
Medical Communications, Sales and Marketing Dovato, Japan, ViiV Healthcare, pharma

Japanโ€™s Ministry of Health, Labour and Welfare (MHLW) has awarded marketing approval to ViiV Healthcare, a subsidiary of GSK, for …

UK trial aims to find treatments that can slow or reverse motor neurone disease

January 17, 2020
Medical Communications MND, Motor Neurone, clinical trial, motor neurone disease, trial

A UK wide trial called MND-SMART has invited hundreds of people with motor neurone disease (MND) to participate. It will …

mask-1954673_1280

Chinaโ€™s viral pneumonia spreads to Japan

January 17, 2020
Medical Communications China, Japan, Sars, Viral pneumonia, Wuhan, epidemic, pandemic, pneumonia

A recent strain of viral pneumonia has spread from China to Japan, prompting fears of a global pandemic. A man …

novo_nordisk_flag

Novo’s semaglutide injection and tablets get expanded FDA approval for type 2 diabetes with established CVD

January 17, 2020
Medical Communications, Sales and Marketing FDA, Novo Nordisk, Ozempic, cardiovascular disease, diabetes, pharma

Novo Nordisk has seen label expansions approved from the FDA for both its glucagon-like peptide-1 (GLP-1) analogue injection Ozempic (once-weekly …

The Gateway to Local Adoption Series

Latest content